$ICON

Conversion of Notes and Allotment of Shares

Iconic Labs PLC (LSE:ICON) said it received a valid conversion notice dated 1 June 2026. One convertible note will convert into 458,716 ordinary shares at GBP 0.0109 per share, for an aggregate principal of GBP 5,000. Application has been made for admission to LSE Main Market, expected around 8 June 2026. Issued share capital will total 16,039,907 shares.

Original reporting
Published Jun 2, 2026, 5:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 5:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Conversion of Notes and Allotment of Shares — source image
Decision brief

The 30-second read

$ICONNeutralMed
01

Why it matters

The key tradable elements are (1) the conversion ratio and price, (2) the resulting increase in issued share capital, and (3) the expected admission date (around 8 June 2026), which can drive short-term supply/demand and valuation adjustments.

02

Market read

A capital-structure event that increases share count via note conversion; likely modest impact concentrated around the admission date.

03

What to watch

Traders should check whether the conversion price (GBP 0.0109) is above/below recent market levels and whether any additional notes are outstanding, which could compound dilution expectations.

Relevance 7/10Novelty 6/10Timing: Ahead of expected LSE admission of the new shares on or around 8 June 2026.

Background

The company is converting a convertible note into equity, triggering admission of newly issued shares to the London Stock Exchange Main Market.

Company-level read

Ticker impact

$ICONNeutralMedium confidence
Context

Iconic Labs received a valid conversion notice converting one convertible note into 458,716 new ordinary shares at GBP 0.0109.

Expected impact

Likely modest, short-lived move around the 8 June 2026 admission as dilution/float increases are priced in.

Evidence & confidence

The announcement is a mechanical capital-structure update (conversion and admission timing) with no stated operating/financial performance change, so impact is typically limited to dilution expectations and trading mechanics.

Market effects

Limited sector read-through; this is company-specific financing mechanics rather than a sector-wide catalyst.

Primarily UK/LSE microstructure impact via admission timing and share count changes.

Low—no cross-border deal, regulator action, or macro linkage described.

Counterpoint

If the convertible note holder is converting rather than selling, the near-term overhang could be smaller than typical dilution fears.

Key entities

  • Iconic Labs PLC

    Subject of the conversion notice; will issue 458,716 ordinary shares following conversion of a convertible note.

Related articles

$TSLAHigh

Tesla (TSLA) Unveils New Roadster, Shares Rise 5% Premarket on G

Tesla (TSLA) announced its new Roadster, set for 2028 production, causing a 5% premarket stock rise. The company's GF Value™ suggests a 5.4% premium over its estimated intrinsic value, with a GF Score™ of 87/100. Insiders sold $87.7M in shares, while 16 premium gurus hold TSLA, with a net positive addition of 2 gurus. The Roadster aims to bolster Tesla's luxury EV lineup, though analysts have mixed views on its near-term revenue impact.

$CRWVMed

CoreWeave (CRWV) Shares Tumble Over 25% Amid Debt Concerns and S

CoreWeave Inc (CRWV) shares fell over 25% due to concerns about high debt levels and broader semiconductor sector weakness. The company's P/S ratio is 4.28, below its historical median, and its GF Score™ is 8/100, indicating financial health challenges. Insiders sold $5.9 billion in shares over the past year, with no purchases. Analysts are divided, citing Nvidia's support as a potential stabilizing factor, but worries about operating margins and borrowing costs persist.

$VSTHighAI 8/10

Should You Buy Vistra After an 11% 1-Day Jump on a $4.2 Billion DOE Loan? The Catch Most Investors Are Missing.

Vistra (VST) shares rose 11% after the U.S. DOE announced a $4.2B loan for nuclear plant upgrades. The loan aims to increase capacity and extend plant life, benefiting from rising electricity demand. Vistra's Q2 2026 EBITDA rose 30% YoY to $1.8B. Analysts rate it a Strong Buy with 11-68% upside potential. The loan is conditional, requiring Vistra to meet various requirements and repay it.